Blood Cancer Journal (Aug 2024)
Safety and efficacy of blinatumomab as bridge-to-transplant for B-cell acute lymphoblastic leukemia in first complete remission with no detectable minimal residual disease
- Jialing Lu,
- Xiebing Bao,
- Jihao Zhou,
- Xiaoli Li,
- Zhewei He,
- Yujie Ji,
- Shengli Xue,
- Suning Chen,
- Depei Wu,
- Qi Hu,
- Peng Ke,
- Xiao Ma
Affiliations
- Jialing Lu
- Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine
- Xiebing Bao
- National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University
- Jihao Zhou
- Department of Hematology, Shenzhen People’s Hospital, Second Clinical Medical College of Jinan University, First Affiliated Hospital of Southern University of Science and Technology
- Xiaoli Li
- Soochow Hopes Hematonosis Hospital
- Zhewei He
- National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University
- Yujie Ji
- National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University
- Shengli Xue
- National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University
- Suning Chen
- National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University
- Depei Wu
- National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University
- Qi Hu
- Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine
- Peng Ke
- Department of Hematology, Shenzhen People’s Hospital, Second Clinical Medical College of Jinan University, First Affiliated Hospital of Southern University of Science and Technology
- Xiao Ma
- National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University
- DOI
- https://doi.org/10.1038/s41408-024-01127-2
- Journal volume & issue
-
Vol. 14,
no. 1
pp. 1 – 5
Abstract
No abstracts available.